First-Line Zongertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. (nejm.org)

Authors: Heymach JV … Popat S Journal: New England Journal of Medicine Published: 2026-04-30 DOI: https://doi.org/10.1056/NEJMoa2516969